Concepedia

Mark Mills

MM

Statistics

Publications

3

Citations

57

H-Index

3

Active since

2011

Affiliations

AstraZeneca (United Kingdom)(Current)

Mark Mills is an author at AstraZeneca (United Kingdom) specializing in medicine, drug discovery, and pharmacology.

Top concepts

Publications per year

2011–2013

3

Publications

3

Hydantoin based inhibitors of MMP13—Discovery of AZD6605

Chris De Savi, David Waterson, Andrew R. Pape et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 22 citations · Full text

, , +5

The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis

Chris De Savi, Andrew R. Pape, John G. Cumming et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 20 citations · Full text

, , +9

Synthesis and evaluation of heteroarylalanine diacids as potent and selective neutral endopeptidase inhibitors

Melanie S. Glossop, Richard Bazin, Kevin N. Dack et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 15 citations · Full text

, , +7

1–3 of 3